(Q51946107)

18 April 2018

title

Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges? (English)

1 reference

18 April 2018

author name string

R J Smith

series ordinal

1

1 reference

18 April 2018

publication date

1 March 2006

1 reference

18 April 2018

Proceedings of the Royal Society B

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 April 2018

volume

273

1 reference

18 April 2018

issue

1586

1 reference

18 April 2018

page(s)

617-624

1 reference

18 April 2018

Hierarchical Bayesian methods for estimation of parameters in a longitudinal HIV dynamic system

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Perspectives on the basic reproductive ratio

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Paradoxes of adherence and drug resistance to HIV antiretroviral therapy

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Protease inhibitor-sparing regimens: new evidence strengthens position

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Addressing the challenges of adherence

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Public health consequences of screening patients for adherence to highly active antiretroviral therapy.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Adherence and drug resistance: predictions for therapy outcome

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Early antiretroviral therapy: rationale, protease inhibitor-sparing regimens and once daily dosing.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Attaining higher goals in HIV treatment: the central importance of adherence

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Use of a stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560063

Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV.

13 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1098%2FRSPB.2005.3352

The era of adherence to HIV therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16537134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monte Carlo estimates of natural variation in HIV infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16537134

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1098/RSPB.2005.3352

1 reference

18 April 2018

PMC publication ID

1560063

1 reference

18 April 2018

PubMed publication ID

16537134

1 reference

18 April 2018